Patent · US Active

Ubiquitin variant modulators of SCF E3 ligases and their uses

US10618942B2 · kind B2 · utility

0Cited by
0References
9Claims
0Family size

Assignees

Inventors

Key dates

Filing dateFeb 17, 2017
Grant dateApr 14, 2020
Priority date—
Expiry dateApr 4, 2037

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/9015
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The invention provides ubiquitin variants that specifically bind to SCF E3 ligases, and use of these variants to modulate the activity of SCF E3 ligases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.